
Neural ID offers a collaborative biosignal analytics platform that supports the full pharmaceutical lifecycle. Its flagship product IWS uses machine learning to reduce massive data and deliver results in a single interoperable data format for discovery, clinical trials, and health information. It is an enterprise-grade B2B solution designed for pharma and life sciences teams. Key technologies include machine learning, data reduction, and a unified data format, enabling collaboration across teams and data sources. The platform aims to improve decision speed, reduce development costs, and support product revenues across the clinical and regulatory pipeline.

Neural ID offers a collaborative biosignal analytics platform that supports the full pharmaceutical lifecycle. Its flagship product IWS uses machine learning to reduce massive data and deliver results in a single interoperable data format for discovery, clinical trials, and health information. It is an enterprise-grade B2B solution designed for pharma and life sciences teams. Key technologies include machine learning, data reduction, and a unified data format, enabling collaboration across teams and data sources. The platform aims to improve decision speed, reduce development costs, and support product revenues across the clinical and regulatory pipeline.